The latest updates and industry activities from GL Biopharm
The company announced the expansion of its functional food and health product pipeline, further deepening the layout of the health industry in the Guangdong Hong Kong Macao Greater Bay Area.
The company's R&D team was invited to attend the International Biomedical Academic Conference to share the latest developments in anti infective new drugs and new vaccine platforms.
The company has signed industry university research cooperation agreements with multiple research institutions to jointly promote the conversion of candidate drugs and functional foods.
The anti infective candidate molecules independently deployed by the company have completed key preclinical pharmacological evaluations, and the data supports further development.
The company leader accepted an exclusive interview with industry media to interpret the differences in functional food regulations between mainland China and Hong Kong and Macao, as well as compliance development strategies.
An invention patent covering the stabilization process of functional formulas has entered the substantive examination stage.
6 items · Page 1 / 1
